Human C-reactive protein regulates myeloma tumor cell growth an...(c target for breaking the vicious circle...),Health
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
MEDICINE
>>
NEWS
Human C-reactive protein regulates myeloma tumor cell growth and survival
c target for breaking the vicious circle of myeloma to improve the the......
http://www.bio-medicine.org/inc/biomed/medicine-news.asp
http://feeds.bio-medicine.org/latest-medical-news
Date:9/10/2007
c target for breaking the vicious circle of myeloma to improve the therapeutic efficacy of currently available treatments, explains Dr. Yi.
'/>"/>
Contact: Nancy Wampler
nwampler@cell.com
617-386-2121
Cell Press
Source:
Eurekalert
0
GOOD
Page:
1
2
Related medicine news :
1
.
Human Genome Project Achieves Technological Triumph
2
.
First Vaccine Designed for Africa Cleared for Testing in Humans
3
.
Controversial deal on public access of the human genome map
4
.
Man against HIV – new vaccine ready for human trials
5
.
Scientists plan human cloning clinic in the United States
6
.
Human gene number increases
7
.
First human clone is near
8
.
Water regulation in humans
9
.
Fossil teeth and human development
10
.
Scientists found ancient Human Germ Killer
11
.
New standards for Human Research Safety
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Breaking Medicine News(10 mins):
Health News:EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families 2
Health News:EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families 3
Health News:The New York Eye and Ear Infirmary Announces Partnership with ZocDoc 2
Health News:Fastrack Announces Major Expansion 2
Health News:Fastrack Announces Major Expansion 3
Health News:Okuma Real Help Machine Tool Giveaway Finalists Announced 2
Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 2
Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 3
[
0
] EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families
[
0
] The New York Eye and Ear Infirmary Announces Partnership with ZocDoc
[
0
] Fastrack Announces Major Expansion
[
0
] Okuma Real Help Machine Tool Giveaway Finalists Announced
[
0
] Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine
Other Medicine News:
Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 2
Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 3
Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 4
Health News:March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis 2
Health News:Differing attitudes found between women and doctors concerning menstrual suppression 2
Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2
Health News:Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson 2
Health News:APHA Deeply Troubled by Bush Veto of CHIP 2
StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles
March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
Differing attitudes found between women and doctors concerning menstrual suppression
Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation
Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
APHA Deeply Troubled by Bush Veto of CHIP
Breaking Medicine Technology:
Ascension Orthopedics Hires Key Senior Executives 2
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4
Daniel K. Spiegelman Elected to Board of Directors of Omeros 2
Health Robotics Announces American Joint Venture With i v SOFT 52770 1
Health Robotics Announces American Joint Venture With i v SOFT 52770 2
Health Robotics Announces American Joint Venture With i v SOFT 52770 3
Cardium Regains Listing Compliance with NYSE Amex 13207 1
Cardium Regains Listing Compliance with NYSE Amex 13207 2
Cardium Regains Listing Compliance with NYSE Amex 13207 3
American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 1
American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 2
American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 3
American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 4
[
0
] Ascension Orthopedics Hires Key Senior Executives
[
0
] Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
[
0
] Daniel K. Spiegelman Elected to Board of Directors of Omeros
Other Medicine Technology:
Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 2
Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus 3
Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile 2
Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile 3
Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Medicine Products:
Nuclear Cardiology Facility Planning Services
Operation Microscope
Mobile Catheterization Laboratories Serving Hospital Networks
VersaPulse 20 Watt
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health